Optimization of Heterologous Expression of Insulin Receptor-Related Receptor Ectodomain


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

In this paper, we present an approach to optimize the heterologous expression of the receptor tyrosine kinase IRR, which further simplifies the purification of the IRR from the medium and increases the final yield. The approach proposed by us can find application in the biotechnological production of other large-scale recombinant proteins produced for medical purposes.

About the authors

A. A. Mozhaev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Shubnikov Institute of Crystallography, Crystallography
and Photonics Federal Research Center, Russian Academy
of Sciences

Author for correspondence.
Email: a.a.mozhaev@gmail.com
Russian Federation, Moscow, 117997; Moscow, 117333

A. N. Orsa

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: a.a.mozhaev@gmail.com
Russian Federation, Moscow, 117997

I. E. Deyev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: a.a.mozhaev@gmail.com
Russian Federation, Moscow, 117997

V. I. Shvets

Institute of Fine Chemical Technology, Russian Technological University (MIREA)

Email: a.a.mozhaev@gmail.com
Russian Federation, Moscow, 117571

A. G. Petrenko

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: a.a.mozhaev@gmail.com
Russian Federation, Moscow, 117997

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Pleiades Publishing, Inc.